Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma.

Journal article

Carroll TM. et al, (2023), Cancer Cell, 41, 1222 - 1241.e7

PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer.

Journal article

Woodcock VK. et al, (2023), BJUI Compass, 4, 322 - 330

Adjuvant Nivolumab Versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results From CheckMate 238.

Journal article

Larkin J. et al, (2023), Clinical cancer research : an official journal of the American Association for Cancer Research

Load More